Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
|Articles|May 15, 2012
HHS Launches Health Data Comparison Tool
Advertisement
A new online tool will allow public searches of disparate federal healthcare data sets in one place.
HHS launched the Health System Measurement Project on Tuesday to allow simplified tracking of healthcare trends in access to care, cost and affordability, disease prevention and health information technology, according to a news release.
Read the full story:
Source: ModernHealthcare.com
Advertisement
Related to this article
AI quantitative CT (UCLA QILD, Brainomix e-Lung) predicts FVC decline and drug response in PPF, strengthening biomarkers beyond spirometry in INBUILD.
The opening session of AAO 2026 featured a keynote speech discussing how artificial intelligence (AI) will play a part in health care.
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher out-of-pocket spending.
Even when physicians prescribe guideline-preferred therapies, step therapy and prior authorization can delay or restrict access to CLL therapies.
The trade group says CMS lacks authority to impose GLOBE, which is set to begin January 1.
Delphi consensus guides dermatology on spotting CTCL vs atopic dermatitis before/after dupilumab, using biopsy plus T-cell clonality testing and safer treatment switches.
Advertisement
Advertisement
Trending on AJMC
1
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
2
Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV
3
New Mechanism of DME Treatment Highlights Clinical Trial Updates
4
Using Complement Inhibitors in GA Comes With Pros and Cons
5